This week's top stories in cardiology: <ol> <li><a href="http://bit.ly/2Y40M1O">Cognitive decline sped up after CHD</a></li> <li><a href="http://bit.ly/2RqoPp0">Genetic analysis links PCSK9 inhibition and CV mortality</a></li> <li><a href="http://bit.ly/2XoLFD2">Which antidiabetic for elderly patients? It depends on their CV risk</a></li> <li><a href="http://bit.ly/2WQuaax">Pivotal trial shows HFrEF benefits from baroreceptor stimulation</a></li> </ol> You can contact the Cardiocast by emailing us at <a href= "mailto:podcasts@mdedge.com">podcasts@mdedge.com</a> or you can interact with us on Twitter <a href= "http://bit.ly/2TYvkPI">@MDedgeCardio</a>

This week's top stories in cardiology: Cognitive decline sped up after CHD Genetic analysis links PCSK9 inhibition and CV mortality Which antidiabetic for elderly patients? It depends on their CV risk Pivotal trial shows HFrEF benefits from baroreceptor stimulation You can contact the Cardiocast by emailing us at podcasts@mdedge.com or you can interact with us on Twitter @MDedgeCardio

This week's top stories in cardiology: <ol> <li><a href="http://bit.ly/2Y40M1O" rel="noopener noreferrer">Cognitive decline sped up after CHD</a></li> <li><a href="http://bit.ly/2RqoPp0" rel="noopener noreferrer">Genetic analysis links PCSK9 inhibition and CV mortality</a></li> <li><a href="http://bit.ly/2XoLFD2" rel="noopener noreferrer">Which antidiabetic for elderly patients? It depends on their CV risk</a></li> <li><a href="http://bit.ly/2WQuaax" rel="noopener noreferrer">Pivotal trial shows HFrEF benefits from baroreceptor stimulation</a></li> </ol> You can contact the Cardiocast by emailing us at <a href="mailto:podcasts@mdedge.com" rel="noopener noreferrer">podcasts@mdedge.com</a>&nbsp;or you can interact with us on Twitter <a href="http://bit.ly/2TYvkPI" rel="noopener noreferrer">@MDedgeCardio</a>

CHD sped cognitive decline; choosing an antidiabetic for elderly patients

MDedge Cardiocast is the weekly podcast from Cardiology News. The information in this podcast is provided for informational and educational purposes only.

Share CHD sped cognitive decline; choosing an antidiabetic for elderly patients

Sign up to save your podcasts

CHD sped cognitive decline; choosing an antidiabetic for elderly patients

CHD sped cognitive decline; choosing an antidiabetic for elderly patients